Abstract
Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline-directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non-adherence represents a critical barrier limiting real-world efficacy of GDMT. This scientific statement aims to provide a comprehensive framework for understanding, measuring, and addressing medication non-adherence in HF management across diverse healthcare settings. Addressing medication non-adherence requires systematic, multifaceted approaches targeting individual patient barriers while implementing system-level interventions. Polypills, digital monitoring platforms, enhanced patient education and empowerment, and multidisciplinary care models represent promising strategies to optimize therapeutic adherence and improve clinical outcomes in HF management.
| Original language | English |
|---|---|
| Pages (from-to) | 2716-2731 |
| Number of pages | 16 |
| Journal | European Journal of Heart Failure |
| Volume | 27 |
| Issue number | 12 |
| Early online date | 9 Nov 2025 |
| DOIs | |
| State | Published - Dec 2025 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2025 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Keywords
- Adherence
- Digital
- Education
- Fixed-dose combinations
- Guidelines
- Heart failure
- Multidisciplinary
- Polypill
Fingerprint
Dive into the research topics of 'Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver